Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
MEET THE TEAM
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
UK Government’s Local Power Plan – what it means for industry
Brevia Energy takes a look at the Local Power Plan, the challenges faced by the Government in its delivery, next steps, and why these developments matter for industry stakeholders.
Government confirms CPI indexation for renewable subsidies
From April 2026, subsidy payments under the RO and FiT will be uprated by CPI rather than RPI, as part of a broader effort to manage electricity system costs. In this article, Brevia Energy explores the rationale behind the reform, the projected consumer savings, and the implications for legacy renewable assets.
DESNZ February Oral Questions – Key Takeaways
DESNZ Ministers appeared in the House of Commons to answer Oral Questions from MPs. Brevia Energy provides the key takeaways.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.